AtonRa Partners’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-13,035
Closed -$74.3K 118
2023
Q1
$74.3K Sell
13,035
-1,877
-13% -$11.3K 0.11% 121
2022
Q4
$150K Sell
14,912
-4,034
-21% -$75.8K 0.19% 111
2022
Q3
$425K Sell
18,946
-528
-3% -$15.3K 0.42% 99
2022
Q2
$483K Sell
19,474
-1,223
-6% -$33.7K 0.44% 105
2022
Q1
$802K Buy
20,697
+4,559
+28% +$177K 0.44% 89
2021
Q4
$944K Buy
16,138
+1,644
+11% +$93.2K 0.33% 95
2021
Q3
$859K Sell
14,494
-8,717
-38% -$684K 0.29% 105
2021
Q2
$2.01M Buy
23,211
+1,344
+6% +$108K 0.74% 63
2021
Q1
$1.8M Sell
21,867
-1,540
-7% -$148K 0.8% 52
2020
Q4
$2.13M Buy
+23,407
New +$1.45M 1.04% 48

Other funds holding FATE